Skip to main content
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.540
-0.050 (-3.14%)
At close: Dec 5, 2025, 4:00 PM EST
1.610
+0.070 (4.55%)
After-hours: Dec 5, 2025, 7:34 PM EST

Akebia Therapeutics Employees

Akebia Therapeutics had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.

Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$1,243,486
Profits / Employee
-$87,873
Market Cap
408.66M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2024181148.38%
Dec 31, 2023167-38-18.54%
Dec 31, 2022205-221-51.88%
Dec 31, 20214264612.11%
Dec 31, 2020380205.56%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Related Stocks

Company Name Employees
UnitedHealth Group 400,000
Johnson & Johnson 138,100
Thermo Fisher Scientific 125,000
Abbott Laboratories 114,000
AstraZeneca 92,900
Novo Nordisk 77,349
Novartis AG 75,883
Merck & Co. 75,000
Employee Rankings

AKBA News

More News